iRenix Medical Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
iRenix Medical General Information
Description
Developer of ophthalmic devices and drugs intended for targeting significant unmet needs within the eye care industry. The company specializes in combining ultrarapid cooling anesthesia with precision motor-driven injection, enabling healthcare providers to improve patients' intravitreal injection experience and allow retina specialists to meet the rapidly growing demand for intravitreal injections.
Contact Information
Website
www.irenix.comCorporate Office
- 350 Cambridge Avenue
- Suite 300
- Palo Alto, CA 94306
- United States
Corporate Office
- 350 Cambridge Avenue
- Suite 300
- Palo Alto, CA 94306
- United States
iRenix Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 08-Jul-2026 | Completed | Generating Revenue | |||
| 4. Seed Round | 02-Jun-2023 | Completed | Startup | |||
| 3. Grant | 01-Jan-2020 | Completed | Startup | |||
| 2. Grant | 01-Jan-2018 | $2.54M | Completed | Startup | ||
| 1. Seed Round | 26-Apr-2017 | Completed | Startup |
iRenix Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed II-B | ||||||||
| Seed II-A | ||||||||
| Seed II | 937,545 | $0.000100 | $0.17 | $2.13 | $2.13 | 1x | $2.13 | 9.32% |
| Seed | 1,590,925 | $0.000100 | $0.01 | $0.11 | $0.11 | 1x | $0.11 | 27.15% |
iRenix Medical Signals
iRenix Medical Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Heroic Ventures | Venture Capital | Minority | ||
| Michigan Biomedical Venture Fund | Venture Capital | Minority | ||
| Small Business Innovation Research and Small Business Technology Transfer Programs | Government | |||
| University of Michigan Endowment | Limited Partner | Minority |
iRenix Medical FAQs
-
When was iRenix Medical founded?
iRenix Medical was founded in 2016.
-
Where is iRenix Medical headquartered?
iRenix Medical is headquartered in Palo Alto, CA.
-
What is the size of iRenix Medical?
iRenix Medical has 5 total employees.
-
What industry is iRenix Medical in?
iRenix Medical’s primary industry is Therapeutic Devices.
-
Is iRenix Medical a private or public company?
iRenix Medical is a Private company.
-
What is iRenix Medical’s current revenue?
The current revenue for iRenix Medical is .
-
How much funding has iRenix Medical raised over time?
iRenix Medical has raised $2.5M.
-
Who are iRenix Medical’s investors?
Heroic Ventures, Michigan Biomedical Venture Fund, Small Business Innovation Research and Small Business Technology Transfer Programs, and University of Michigan Endowment have invested in iRenix Medical.
-
When was iRenix Medical acquired?
iRenix Medical was acquired on 08-Jul-2026.
-
Who acquired iRenix Medical?
iRenix Medical was acquired by Tarsus Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process